- Anatomy Of The National Drug Code
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Differences Between The DSCSA, FDA Rules and Guidance
- DSCSA: Special Privileges For The "Big-3" Wholesale Distributors, Part 1
- The 2014 FDA DSCSA Workshop
- The Aggregation Hoax and PIA
- DSCSA: Special Privileges For The “Big-3″ Wholesale Distributors, Part 2
Posts Tagged ‘Supply Network Blog’
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
The first website I visit on Monday mornings is RxTrace
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
RxTrace is the most informative and most current source for information on tracking pharma using AIDC. Their integration of information on UDI is also rather unique. RxTrace serves the pharma stakeholders as the pharma business model evolves to include services enabled by AIDC.
Easy to understand summary and discussion of complex current topics.
RxTrace offers unique context and focus on our industry.
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
Ranbaxy Laboratories may face another hefty fine in the US of Rs 240 crore - The Economic Times lnkd.in/bs2MwzK
India's Data Integrity Problems lnkd.in/bW9SYiK
August 18, 2014 (9:20)
2014 Fall Conference Season PreviewDirk, thanks for the list. I'll be at the GS1 and HDMA events. Thinking about...
Ray Vrabel, PharmD
August 13, 2014 (12:13)
The Case Against RFID In PharmaDirk, While you could start with DEA Schedule II medications (e.g., the mo...
August 12, 2014 (2:42)
The Case Against RFID In PharmaFully agree.... now if we could get the S. Korea regulatory agency to drop RF...
Dirk A. Rodgers
August 12, 2014 (12:39)
The Case Against RFID In PharmaRay, Great point and well said. I agree with you. In that case, RFID tags s...
Ray Vrabel, PharmD
August 12, 2014 (12:03)
The Case Against RFID In PharmaIt may be difficult to justify the use of RFID in the supply chain for all ty...